NRAS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.823610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.408100E-02
Normal-vs-Stage2
2.246400E-01
Normal-vs-Stage3
1.986020E-02
Normal-vs-Stage4
8.767400E-01
Stage1-vs-Stage2
2.247400E-01
Stage1-vs-Stage3
7.659400E-01
Stage1-vs-Stage4
8.748000E-02
Stage2-vs-Stage3
1.782790E-01
Stage2-vs-Stage4
1.079370E-01
Stage3-vs-Stage4
6.469600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.681410E-01
Normal-vs-AfricanAmerican
5.717800E-01
Normal-vs-Asian
1.482790E-01
Caucasian-vs-AfricanAmerican
3.730600E-01
Caucasian-vs-Asian
7.752200E-01
AfricanAmerican-vs-Asian
3.951800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.227040E-01
Normal-vs-Female
2.869800E-01
Male-vs-Female
9.411900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.410000E-01
Normal-vs-Age(41-60Yrs)
4.326200E-01
Normal-vs-Age(61-80Yrs)
1.192800E-01
Normal-vs-Age(81-100Yrs)
6.328400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.850800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.569200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.240800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.099200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.889700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.621600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.204000E-02
Normal-vs-Daily Drinker
1.315230E-01
Normal-vs-Weekly Drinker
1.637170E-01
Normal-vs-Occasional Drinker
4.668000E-01
Normal-vs-Social Drinker
1.947050E-01
Non Drinker-vs-Daily Drinker
7.477600E-01
Non Drinker-vs-Weekly Drinker
9.128600E-01
Non Drinker-vs-Occasional Drinker
3.879500E-02
Non Drinker-vs-Social Drinker
4.660000E-01
Daily Drinker-vs-Weekly Drinker
8.919200E-01
Daily Drinker-vs-Occasional Drinker
1.373030E-01
Daily Drinker-vs-Social Drinker
7.164400E-01
Weekly Drinker-vs-Occasional Drinker
1.664590E-01
Weekly Drinker-vs-Social Drinker
6.654200E-01
Occasional Drinker-vs-Social Drinker
3.096200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.656200E-01
Normal-vs-Grade 2
9.955600E-01
Normal-vs-Grade 3
9.754400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.431800E-02
Grade 1-vs-Grade 3
2.077600E-02
Grade 1-vs-Grade 4
8.656200E-01
Grade 2-vs-Grade 3
4.873000E-01
Grade 2-vs-Grade 4
9.955600E-01
Grade 3-vs-Grade 4
9.754400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.629900E-02
Normal-vs-NonDiabetic
1.306210E-01
Diabetic-vs-NonDiabetic
3.332200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.444000E-02
Normal-vs-NoPancreatitis
1.323840E-01
Pancreatitis-vs-NoPancreatitis
7.378400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.658200E-02
Normal-vs-N1
2.513000E-01
N0-vs-N1
5.636400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.644400E-01
Normal-vs-TP53-NonMutant
1.104980E-01
TP53-Mutant-vs-TP53-NonMutant
1.641840E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
